India Genetic Testing Market

Genetic testing market in India was initially limited to very few organizations in the country, which possessed both the expertise and the capability to conduct screening tests with assurance. The horizon is expanding gradually in the field of identifying DNA and might grow into humungous proportions if growth drivers are properly put into place. More and more laboratories with advanced equipments are now mushrooming to handle the increasing demands and provide people with the test results, as quickly as possible.There has a been a upsurge in the genetic diseases in India with congenital malformations and genetic disorders being the third most common cause of mortality in newborns. Hence there is a need for adequate and effective genetic testing and counselling services. There are multiple reasons for this rise and can be summarized as consanguinity, high birth rate, improved diagnostic facilities, and a lack of expertise in genetic counselling
To Know More -  India Genetic Testing Market.

Top Ten Suppliers of Synthetic Biology Technology

Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.”
These advances also mark an economic turning point, creating a market vision of synthetic life forms and life processes tailored to produce specific substances. The desired yield of such substances as biofuels can be measured in millions of tons, whereas pharmaceuticals can be measured in grams or milligrams.
The door that is opening is likely to affect important markets for decades. Intense research and development continues to be both privately and publically funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.
The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.
To Know More -   Synthetic Biology Technology

Animal Biotechnology Markets and Companies

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture. Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

To Know More - Animal Biotechnology Markets and Companies.

US biotechnology industry revenues have increased from USD 73 billion in 2006 to USD ~ billion in 2011 by growing at a CAGR of ~% during 2006-2011

The report titled ‘The US Biotechnology Market Outlook to 2016 – Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector’ provides a detailed description of the biotechnology market scenario in the US and a comprehensive analysis of the various qualitative and quantitative factors that are influencing the market. The report depicts the size of the biotech industry, biopharmaceuticals, biopesticides and bioseeds, biofuel and bioenzymes segments in the US, a competitive landscape and profiles of key players in these segments and the recent trends and developments in the biotechnology market in the US. The report also covers future outlook and projections for the different segments as well as the overall US biotechnology market on the basis of several industry factors that will shape the growth of this market in next five years.

To Know More : The US Biotechnology Market Outlook to 2016 - Future Growth Led by Surging Biotech Application in Agriculture, Health and Industrial Sector

Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016

Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical – Global Trends & Competitive Analysis
The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016. 

To Know More - Ablation Technologies Market (2011-2016) - Global Trends & Competitive Analysis

The Global Biometrics Market in 2012 at $7.59bn.

The unique capabilities of biometric identification technologies provide solutions to a range of security issues for both military and civilian markets. With technological advances now ensuring greater effectiveness, and multi-modular identification systems able to integrate several methods of identification, biometric technology systems are increasingly vital components for the digital age. values the global Biometrics Market in 2012 at $7.59bn.

To Know More - The Biometrics Market 2012-2022

Mesenchymal Stem Cells (MSCs) Increased 112% from 2009 to 2010, and 116% from 2010 to 2011

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells. MSCs are of intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases.

To Know More - Mesenchymal Stem Cells - Advances And Applications